{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T22:01:46Z","timestamp":1768773706913,"version":"3.49.0"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Cerebral cytokinopathies are key examples of dysregulated cytokine responses. While mouse models with targeted production of individual cytokines have been pivotal in establishing a causal link between cytokines and disease\u2014 especially in the central nervous system\u2014they often fail to replicate the complex inflammatory environments seen in various neuropathological conditions, such as neuromyelitis optica spectrum disorder, where multiple cytokines are upregulated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To address this, we developed a novel mouse model, GFAP-IL6-IFN<jats:italic><jats:sup>lo<\/jats:sup><\/jats:italic> mice, by combining transgenic mice with astrocyte-targeted production of IL-6 (GFAP-IL6 mice) and IFN-\u03b1 (GFAP-IFN<jats:italic><jats:sup>lo<\/jats:sup><\/jats:italic> mice).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our findings reveal that chronic, low-level production of IFN-\u03b1, below the typical disease-inducing threshold, significantly accelerates disease progression in GFAP-IL6-IFN<jats:italic><jats:sup>lo<\/jats:sup><\/jats:italic> mice compared to GFAP-IL6 mice. The double transgenic mice exhibited progressive ataxia, persistent seizure-like episodes, and reduced survival. Remarkably, the clinical and pathological symptoms remained predominantly IL-6-driven and required the presence of adaptive immune cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In summary, we demonstrate that subclinical levels of IFN-\u03b1 can markedly exacerbate IL-6-mediated neurological disease, suggesting that future studies, should consider the combined effects of IL-6 and IFN-\u03b1.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnins.2025.1586400","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T09:58:38Z","timestamp":1750327118000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Interleukin-6-induced neuroinflammation is exacerbated by subclinical levels of interferon-\u03b1"],"prefix":"10.3389","volume":"19","author":[{"given":"Pattama","family":"Songkhunawej","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus J.","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1038\/s41467-020-16625-7","article-title":"Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica.","volume":"11","author":"Agasing","year":"2020","journal-title":"Nat. Commun."},{"key":"B2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/ana.410150109","article-title":"progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis.","volume":"15","author":"Aicardi","year":"1984","journal-title":"Ann. Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"5016","DOI":"10.4049\/jimmunol.161.9.5016","article-title":"Transgenic expression of IFN-\u03b1 in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration.","volume":"161","author":"Akwa","year":"1998","journal-title":"J. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s10165-012-0715-9","article-title":"Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab.","volume":"23","author":"Araki","year":"2013","journal-title":"Mod. Rheumatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1212\/WNL.0000000000000317","article-title":"Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: A pilot study.","volume":"82","author":"Araki","year":"2014","journal-title":"Neurology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1093\/brain\/awad373","article-title":"Interferon-\u03b3 controls aquaporin 4-specific Th17 and B cells in neuromyelitis optica spectrum disorder.","volume":"147","author":"Arellano","year":"2024","journal-title":"Brain"},{"key":"B7","doi-asserted-by":"publisher","first-page":"7832","DOI":"10.1128\/JVI.71.10.7832-7840.1997","article-title":"Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis.","volume":"71","author":"Asensio","year":"1997","journal-title":"J. Virol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3109\/13550289909029747","article-title":"Chemokines and the inflammatory response to viral infection in the central nervous system with a focus on lymphocytic choriomeningitis virus.","volume":"5","author":"Asensio","year":"1999","journal-title":"J. Neurovirol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"7067","DOI":"10.1128\/JVI.75.15.7067-7077.2001","article-title":"Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10\/IP-10 gene expression by astrocytes in vivo and in vitro.","volume":"75","author":"Asensio","year":"2001","journal-title":"J. Virol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"713519","DOI":"10.1155\/2013\/713519","article-title":"Interferon \u03b1 association with neuromyelitis optica.","volume":"2013","author":"Asgari","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1001\/jamaneurol.2013.1246","article-title":"Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy.","volume":"70","author":"Ayzenberg","year":"2013","journal-title":"JAMA Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/(SICI)1098-1136(199610)18:2107::AID-GLIA33.0.CO;2-Y","article-title":"Chronic complement C3 gene expression in the CNS of transgenic mice with astrocyte-targeted interleukin-6 expression.","volume":"18","author":"Barnum","year":"1996","journal-title":"Glia"},{"key":"B13","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1097\/00005072-199511000-00003","article-title":"Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes.","volume":"54","author":"Brett","year":"1995","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"10061","DOI":"10.1073\/pnas.90.21.10061","article-title":"Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6.","volume":"90","author":"Campbell","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1523\/JNEUROSCI.2830-13.2014","article-title":"Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain.","volume":"34","author":"Campbell","year":"2014","journal-title":"J. Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/s0006-8993(99)01328-1","article-title":"Structural and functional neuropathology in transgenic mice with CNS expression of IFN-\u03b1.","volume":"835","author":"Campbell","year":"1999","journal-title":"Brain Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4859","DOI":"10.4049\/jimmunol.161.9.4859","article-title":"Astrocyte-targeted expression of IFN-\u03b11 protects mice from acute ocular herpes simplex virus type 1 infection.","volume":"161","author":"Carr","year":"1998","journal-title":"J. Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1182\/blood-2007-05-091207","article-title":"STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier.","volume":"111","author":"Chaudhuri","year":"2008","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000112109","article-title":"Reactive gliosis as a consequence of interleukin-6 expression in the brain: Studies in transgenic mice.","volume":"16","author":"Chiang","year":"1994","journal-title":"Dev. Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/ajmg.a.36887","article-title":"Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1.","author":"Crow","year":"2015","journal-title":"Am. J. Med. Genet. A"},{"key":"B21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/brain\/aws321","article-title":"Chronic exposure of astrocytes to interferon-\u03b1 reveals molecular changes related to Aicardi-Goutieres syndrome.","volume":"136","author":"Cuadrado","year":"2013","journal-title":"Brain"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1038\/sj.onc.1203481","article-title":"Serine phosphorylation of STATs.","volume":"19","author":"Decker","year":"2000","journal-title":"Oncogene"},{"key":"B23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1475-1313.2009.00703.x","article-title":"pH dependent spectral properties of sodium fluorescein ophthalmic solutions revisited.","volume":"30","author":"Doughty","year":"2010","journal-title":"Ophthalmic. Physiol. Opt."},{"key":"B24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/bpa.12793","article-title":"Experimental animal models of aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders: Progress and shortcomings.","volume":"30","author":"Duan","year":"2020","journal-title":"Brain Pathol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.4049\/jimmunol.168.7.3195","article-title":"IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking.","volume":"168","author":"Dufour","year":"2002","journal-title":"J. Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2015.08.069","article-title":"Lack of Neuronal IFN-\u03b2-IFNAR Causes Lewy Body- and Parkinson\u2019s Disease-like Dementia.","volume":"163","author":"Ejlerskov","year":"2015","journal-title":"Cell"},{"key":"B27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/s0165-5728(02)00182-0","article-title":"Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1.","volume":"129","author":"Feng","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jns.2011.09.032","article-title":"Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis.","volume":"313","author":"Feng","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e841","DOI":"10.1212\/NXI.0000000000000841","article-title":"Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology.","volume":"7","author":"Fujihara","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"B30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.msard.2019.04.023","article-title":"Neuromyelitis optica spectrum disorder occurred after interferon \u03b1 therapy in malignant melanoma.","volume":"32","author":"Gao","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"B31","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/glia.22457","article-title":"Induction of atypical EAE mediated by transgenic production of IL-6 in astrocytes in the absence of systemic IL-6.","volume":"61","author":"Giralt","year":"2013","journal-title":"Glia"},{"key":"B32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3389\/fnins.2019.00303","article-title":"Chronic microglial activation in the GFAP-IL6 mouse contributes to age-dependent cerebellar volume loss and impairment in motor function.","volume":"13","author":"Gyengesi","year":"2019","journal-title":"Front. Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1073\/pnas.94.4.1500","article-title":"Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain.","volume":"94","author":"Heyser","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.4049\/jimmunol.150.8.3602","article-title":"Patterns of cytokine gene expression by CD4+ T cells from young and old mice.","volume":"150","author":"Hobbs","year":"1993","journal-title":"J. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2055217319848463","DOI":"10.1177\/2055217319848463","article-title":"Distinct serum and cerebrospinal fluid cytokine and chemokine profiles in autoantibody-associated demyelinating diseases.","volume":"5","author":"Hofer","year":"2019","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1523\/JNEUROSCI.3711-09.2010","article-title":"The type I interferon-alpha mediates a more severe neurological disease in the absence of the canonical signaling molecule interferon regulatory factor 9.","volume":"30","author":"Hofer","year":"2010","journal-title":"J. Neurosci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"107666","DOI":"10.1016\/j.celrep.2020.107666","article-title":"Type I interferon receptor signaling in astrocytes regulates hippocampal synaptic plasticity and cognitive function of the healthy CNS.","volume":"31","author":"Hosseini","year":"2020","journal-title":"Cell Rep."},{"key":"B38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses.","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1177\/1352458512459290","article-title":"Efficacy and safety of beta-interferon in Thai patients with demyelinating diseases.","volume":"19","author":"Jarernsook","year":"2013","journal-title":"Mult. Scler."},{"key":"B40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/s1074-7613(03)00208-5","article-title":"Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6.","volume":"19","author":"Jego","year":"2003","journal-title":"Immunity"},{"key":"B41","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/978-1-61779-191-8_25","article-title":"Assessment of permeability in barrier type of endothelium in brain using tracers: Evans blue, sodium fluorescein, and horseradish peroxidase.","volume":"763","author":"Kaya","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1177\/1352458512439439","article-title":"Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder?","volume":"18","author":"Kim","year":"2012","journal-title":"Mult. Scler."},{"key":"B43","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/acn3.213","article-title":"Interferon-\u03b1 and the calcifying microangiopathy in Aicardi-Gouti\u00e8res syndrome.","volume":"2","author":"Klok","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/emboj\/20.1.91","article-title":"Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression.","volume":"20","author":"Kovarik","year":"2001","journal-title":"EMBO J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1212\/WNL.0000000000002228","article-title":"Neuroradiologic patterns and novel imaging findings in Aicardi-Gouti\u00e8res syndrome.","volume":"86","author":"La Piana","year":"2016","journal-title":"Neurology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0022-510x(88)90125-6","article-title":"Intrathecal synthesis of interferon-\u03b1 in infants with progressive familial encephalopathy.","volume":"84","author":"Lebon","year":"1988","journal-title":"J. Neurol. Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1136\/bmj.287.6400.1165","article-title":"Synthesis of intrathecal interferon in systemic lupus erythematosus with neurological complications.","volume":"287","author":"Lebon","year":"1983","journal-title":"Br. Med. J. (Clin Res Ed)"},{"key":"B48","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1074\/jbc.M116.756510","article-title":"Type I interferon-regulated gene expression and signaling in murine mixed glial cells lacking signal transducers and activators of transcription 1 or 2 or interferon regulatory factor 9.","volume":"292","author":"Li","year":"2017","journal-title":"J. Biol. Chem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10875-020-00952-x","article-title":"Differential expression of interferon-\u03b1 protein provides clues to tissue specificity across Type I interferonopathies.","volume":"41","author":"Lodi","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0002-9440(10)64371-4","article-title":"Regulation of signal transducer and activator of transcription and suppressor of cytokine-signaling gene expression in the brain of mice with astrocyte-targeted production of interleukin-12 or experimental autoimmune encephalomyelitis.","volume":"160","author":"Maier","year":"2002","journal-title":"Am. J. Pathol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e61835","DOI":"10.1371\/journal.pone.0061835","article-title":"Characteristic cerebrospinal fluid cytokine\/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.","volume":"8","author":"Matsushita","year":"2013","journal-title":"PLoS One"},{"key":"B52","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1046\/j.1365-2443.2001.00448.x","article-title":"Cross talk of the interferon-\u03b1\/\u03b2 signalling complex with gp130 for effective interleukin-6 signalling.","volume":"6","author":"Mitani","year":"2001","journal-title":"Genes Cells"},{"key":"B53","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/0092-8674(92)90030-g","article-title":"RAG-1-deficient mice have no mature B and T lymphocytes.","volume":"68","author":"Mombaerts","year":"1992","journal-title":"Cell"},{"key":"B54","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.bbi.2015.04.009","article-title":"Interdependent and independent roles of type I interferons and IL-6 in innate immune, neuroinflammatory and sickness behaviour responses to systemic poly I:c.","volume":"48","author":"Murray","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"B55","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1089\/107999003765027384","article-title":"IRAK-dependent phosphorylation of Stat1 on serine 727 in response to interleukin-1 and effects on gene expression.","volume":"23","author":"Nguyen","year":"2003","journal-title":"J. Interferon Cytokine Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"33361","DOI":"10.1074\/jbc.M105070200","article-title":"Roles of phosphatidylinositol 3-kinase in interferon-gamma-dependent phosphorylation of STAT1 on serine 727 and activation of gene expression.","volume":"276","author":"Nguyen","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1001\/archneurol.2010.188","article-title":"Interferon Beta treatment in neuromyelitis optica: Increase in relapses and aquaporin 4 antibody titers.","volume":"67","author":"Palace","year":"2010","journal-title":"Arch. Neurol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.4049\/jimmunol.0900242","article-title":"Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis.","volume":"183","author":"Quintana","year":"2009","journal-title":"J. Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"872684","DOI":"10.3389\/fneur.2022.872684","article-title":"Case report: Interferon-alpha-induced neuromyelitis optica spectrum disorder.","volume":"13","author":"Rao","year":"2022","journal-title":"Front. Neurol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1001\/jamaneurol.2015.0533","article-title":"Long-term therapy with interleukin 6 receptor blockade in highly active neuromyelitis optica spectrum disorder.","volume":"72","author":"Ringelstein","year":"2015","journal-title":"JAMA Neurol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/jnr.10635","article-title":"Profound increase in sensitivity to glutamatergic- but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6.","volume":"73","author":"Samland","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/glia.20602","article-title":"Minimal role for STAT1 in interleukin-6 signaling and actions in the murine brain.","volume":"56","author":"Sanz","year":"2008","journal-title":"Glia"},{"key":"B63","doi-asserted-by":"publisher","first-page":"51605","DOI":"10.3791\/51605","article-title":"Behavioral assessment of the aging mouse vestibular system.","volume":"89","author":"Tung","year":"2014","journal-title":"J. Vis. Exp."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1177\/1352458510379247","article-title":"Cytokine and chemokine profiles in neuromyelitis optica: Significance of interleukin-6.","volume":"16","author":"Uzawa","year":"","journal-title":"Mult. Scler."},{"key":"B65","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/j.1468-1331.2009.02897.x","article-title":"Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis.","volume":"17","author":"Uzawa","year":"","journal-title":"Eur. J. Neurol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1007\/s00415-009-5274-4","article-title":"Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis.","volume":"256","author":"Uzawa","year":"2009","journal-title":"J. Neurol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.cca.2017.03.006","article-title":"Interleukin-6 analysis of 572 consecutive CSF samples from neurological disorders: A special focus on neuromyelitis optica.","volume":"469","author":"Uzawa","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"B68","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/glia.20639","article-title":"Astrocytes produce interferon-\u03b1 and CXCL10, but not IL-6 or CXCL8, in Aicardi-Gouti\u00e8res syndrome.","volume":"56","author":"van Heteren","year":"2008","journal-title":"Glia"},{"key":"B69","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/s1074-7613(03)00322-4","article-title":"Phosphorylation of the Stat1 transactivation domain is required for full-fledged IFN-gamma-dependent innate immunity.","volume":"19","author":"Varinou","year":"2003","journal-title":"Immunity"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.immuni.2024.05.017","article-title":"The brain microvasculature is a primary mediator of interferon-\u03b1 neurotoxicity in human cerebral interferonopathies.","volume":"57","author":"Viengkhou","year":"","journal-title":"Immunity"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e169562","DOI":"10.1172\/JCI169562","article-title":"Interferon-\u03b1 receptor antisense oligonucleotides reduce neuroinflammation and neuropathology in a mouse model of cerebral interferonopathy.","volume":"134","author":"Viengkhou","year":"","journal-title":"J. Clin. Invest."},{"key":"B72","doi-asserted-by":"publisher","first-page":"8295","DOI":"10.1128\/JVI.79.13.8295-8302.2005","article-title":"Innate STAT1-dependent genomic response of neurons to the antiviral cytokine \u03b1 interferon.","volume":"79","author":"Wang","year":"2005","journal-title":"J. Virol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1172\/JCI18637","article-title":"Dysregulated Sonic hedgehog signaling and medulloblastoma consequent to IFN-\u03b1-stimulated STAT2-independent production of IFN-gamma in the brain.","volume":"112","author":"Wang","year":"2003","journal-title":"J. Clin. Invest."},{"key":"B74","doi-asserted-by":"publisher","first-page":"16209","DOI":"10.1073\/pnas.252454799","article-title":"STAT1 deficiency unexpectedly and markedly exacerbates the pathophysiological actions of IFN-\u03b1 in the central nervous system.","volume":"99","author":"Wang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B75","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0092-8674(95)90311-9","article-title":"Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation.","volume":"82","author":"Wen","year":"1995","journal-title":"Cell"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1002\/glia.23634","article-title":"Microglia responses to interleukin-6 and type I interferons in neuroinflammatory disease.","volume":"67","author":"West","year":"2019","journal-title":"Glia"},{"key":"B77","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12974-022-02441-x","article-title":"The cytokines interleukin-6 and interferon-\u03b1 induce distinct microglia phenotypes.","volume":"19","author":"West","year":"","journal-title":"J. Neuroinflamm."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1036799","DOI":"10.3389\/fimmu.2022.1036799","article-title":"Microglia shield the murine brain from damage mediated by the cytokines IL-6 and IFN-\u03b1.","volume":"13","author":"West","year":"","journal-title":"Front. Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1474-4422(19)30445-4","article-title":"Neuromyelitis optica in patients with increased interferon \u03b1 concentrations.","volume":"19","author":"Williams","year":"2020","journal-title":"Lancet Neurol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5692\/clinicalneurol.52.19","article-title":"[Case of NMO (neuromyelitis optica) spectum disorder triggered by interferon \u03b1, which involved extensive pyramidal tract lesion of the brain].","volume":"52","author":"Yamasaki","year":"2012","journal-title":"Rinsho Shinkeigaku"},{"key":"B81","doi-asserted-by":"publisher","first-page":"6963","DOI":"10.1093\/emboj\/17.23.6963","article-title":"Ser727-dependent recruitment of MCM5 by Stat1alpha in IFN-gamma-induced transcriptional activation.","volume":"17","author":"Zhang","year":"1998","journal-title":"EMBO J."},{"key":"B82","doi-asserted-by":"publisher","first-page":"6618","DOI":"10.1128\/MCB.17.11.6618","article-title":"Stat1 serine phosphorylation occurs independently of tyrosine phosphorylation and requires an activated Jak2 kinase.","volume":"17","author":"Zhu","year":"1997","journal-title":"Mol. Cell Biol."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1586400\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T09:58:39Z","timestamp":1750327119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1586400\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":82,"alternative-id":["10.3389\/fnins.2025.1586400"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2025.1586400","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"article-number":"1586400"}}